Company intelligence / Profile preview

Zhejiang Xingyue Biotechnology

Hangzhou (Future Sci-Tech City), Zhejiang Sheng/Zhejiang Province, Chinacmocro.com ↗

Ownership: Private
Development stage: Commercial

Overview

Zhejiang Xingyue Biotechnology has pioneered China’s first bioresorbable silk fibroin medical devices such as hernia repair patches and wound dressings. These products are marketed and used clinically for their biocompatibility and wound healing properties[2]. The company also sponsors clinical trials of autologous adipose-derived mesenchymal stem cells for tendon diseases; at least one trial reached Phase 2[1][5].

Therapeutic areas: GastroenterologyDermatologyRheumatology
Modalities: Cell therapyBiomaterial-based device
Industry: Biotech

Beyond the preview

Go deeper on Zhejiang Xingyue Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Xingyue Biotechnology.

Explore the full profile